White Coat Notes
Can Harvard retain key cancer grant?
Leaders at the Dana-Farber Cancer Institute remain tight-lipped about whether federal officials will renew a major grant for cancer research across Harvard Medical School, Harvard School of Public Health, and five of its teaching hospitals including Dana-Farber -- seen as a major test of whether these ultra-competitive institutions actually can cooperate on research projects. (Full article: 544 words)
This article is available in our archives:
Globe Subscribers
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly





